Accès gratuit
Numéro
Med Sci (Paris)
Volume 31, Numéro 6-7, Juin–Juillet 2015
Page(s) 617 - 621
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20153106014
Publié en ligne 7 juillet 2015
  1. Gould SR, Brash AR, Conolly ME. Increased prostaglandin production in ulcerative colitis. Lancet 1977 ; 2 : 98. [CrossRef]
  2. Murakami M, Naraba H, Tanioka T, et al. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem 2000 ; 275 : 32783–32792. [CrossRef] [PubMed]
  3. Sharon P, Ligumsky M, Rachmilewitz D, Zor U. Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. Gastroenterology 1978 ; 75 : 638–640. [PubMed]
  4. Rodriguez-Lagunas MJ, Martin-Venegas R, Moreno JJ, Ferrer R. PGE2 promotes Ca2+-mediated epithelial barrier disruption through EP1 and EP4 receptors in Caco-2 cell monolayers. Am J Physiol Cell Physiol 2010 ; 299 : C324–C334. [CrossRef] [PubMed]
  5. Ajuebor MN, Singh A, Wallace JL. Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis. Am J Physiol Gastrointest Liver Physiol 2000 ; 279 : G238–G244. [PubMed]
  6. Vong L, Ferraz JG, Panaccione R, et al. A pro-resolution mediator, prostaglandin D(2), is specifically up-regulated in individuals in long-term remission from ulcerative colitis. Proc Natl Acad Sci USA 2010 ; 107 : 12023–12027. [CrossRef]
  7. Zamuner SR, Bak AW, Devchand PR, Wallace JL. Predisposition to colorectal cancer in rats with resolved colitis: role of cyclooxygenase-2-derived prostaglandin d2. Am J Pathol 2005 ; 167 : 1293–1300. [CrossRef] [PubMed]
  8. Hokari R, Kurihara C, Nagata N, et al. Increased expression of lipocalin-type-prostaglandin D synthase in ulcerative colitis and exacerbating role in murine colitis. Am J Physiol Gastrointest Liver Physiol 2011 ; 300 : G401–G408. [CrossRef] [PubMed]
  9. Smith WL, Urade Y, Jakobsson PJ. Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis. Chem Rev 2011 ; 111 : 5821–5865. [CrossRef] [PubMed]
  10. Malki S, Declosmenil F, Farhat A, et al. La prostaglandine D2 - Nouveaux rôles dans la gonade embryonnaire et pathologique. Med Sci (Paris) 2008 ; 24 : 177–183. [CrossRef] [EDP Sciences] [PubMed]
  11. Urade Y, Fujimoto N, Hayaishi O. Purification and characterization of rat brain prostaglandin D synthetase. J Biol Chem 1985 ; 260 : 12410–12415. [PubMed]
  12. Kanaoka Y, Fujimori K, Kikuno R, et al. Structure and chromosomal localization of human and mouse genes for hematopoietic prostaglandin D synthase. Conservation of the ancestral genomic structure of sigma-class glutathione S-transferase. Eur J Biochem 2000 ; 267 : 3315–3322. [CrossRef] [PubMed]
  13. Hokari R, Nagata N, Kurihara C, et al. Increased expression and cellular localization of lipocalin-type prostaglandin D synthase in Helicobacter pylori-induced gastritis. J Pathol 2009 ; 219 : 417–426. [CrossRef] [PubMed]
  14. Park JM, Kanaoka Y, Eguchi N, et al. Hematopoietic prostaglandin D synthase suppresses intestinal adenomas in ApcMin/+ mice. Cancer Res 2007 ; 67 : 881–889. [CrossRef] [PubMed]
  15. Bach-Ngohou K, Mahe MM, Aubert P, et al. Enteric glia modulate epithelial cell proliferation and differentiation through 15-deoxy-12, 14-prostaglandin J2. J Physiol 2010 ; 588 : 2533–2544. [CrossRef] [PubMed]
  16. Boie Y, Sawyer N, Slipetz DM, et al. Molecular cloning and characterization of the human prostanoid DP receptor. J Biol Chem 1995 ; 270 : 18910–18916. [CrossRef] [PubMed]
  17. Hammad H, Kool M, Soullie T, et al. Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells. J Exp Med 2007 ; 204 : 357–367. [CrossRef] [PubMed]
  18. Rajakariar R, Hilliard M, Lawrence T, et al. Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2. Proc Natl Acad Sci USA 2007 ; 104 : 20979–20984. [CrossRef]
  19. Ishii M, Asano K, Namkoong H, et al. CRTH2 is a critical regulator of neutrophil migration and resistance to polymicrobial sepsis. J Immunol 2012 ; 188 : 5655–5664. [CrossRef]
  20. Satoh T, Moroi R, Aritake K, et al. Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor. J Immunol 2006 ; 177 : 2621–2629. [CrossRef]
  21. Ricote M, Li AC, Willson TM, et al. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998 ; 391 : 79–82. [CrossRef] [PubMed]
  22. Zamuner SR, Warrier N, Buret AG, et al. Cyclooxygenase 2 mediates post-inflammatory colonic secretory and barrier dysfunction. Gut 2003 ; 52 : 1714–1720. [CrossRef] [PubMed]
  23. Sturm EM, Radnai B, Jandl K, et al. Opposing roles of prostaglandin D2 receptors in ulcerative colitis. J Immunol 2014 ; 193 : 827–839. [CrossRef]
  24. Hawcroft G, Gardner SH, Hull MA. Expression of prostaglandin D2 receptors DP1 and DP2 by human colorectal cancer cells. Cancer Lett 2004 ; 210 : 81–84. [CrossRef] [PubMed]
  25. Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998 ; 391 : 82–86. [CrossRef] [PubMed]
  26. Peyrin-Biroulet L, Beisner J, Wang G, et al. Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon. Proc Natl Acad Sci USA 2010 ; 107 : 8772–8777. [CrossRef]
  27. Castrillo A, Diaz-Guerra MJ, Hortelano S, et al. Inhibition of IkappaB kinase and IkappaB phosphorylation by 15-deoxy-Delta(12, 14)-prostaglandin J(2) in activated murine macrophages. Mol Cell Biol 2000 ; 20 : 1692–1698. [CrossRef] [PubMed]
  28. Hansson GC. Role of mucus layers in gut infection and inflammation. Curr Opin Microbiol 2012 ; 15 : 57–62. [CrossRef] [PubMed]
  29. Dubuquoy L, Jansson EA, Deeb S, et al. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology 2003 ; 124 : 1265–1276. [CrossRef] [PubMed]
  30. Choi YH, Lee SN, Aoyagi H, et al. The extracellular signal-regulated kinase mitogen-activated protein kinase/ribosomal S6 protein kinase 1 cascade phosphorylates cAMP response element-binding protein to induce MUC5B gene expression via D-prostanoid receptor signaling. J Biol Chem 2011 ; 286 : 34199–34214. [CrossRef] [PubMed]
  31. Wright DH, Ford-Hutchinson AW, Chadee K, Metters KM. The human prostanoid DP receptor stimulates mucin secretion in LS174T cells. Br J Pharmacol 2000 ; 131 : 1537–1545. [CrossRef] [PubMed]
  32. Velcich A, Yang W, Heyer J, et al. Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 2002 ; 295 : 1726–1729. [CrossRef] [PubMed]
  33. Buisine MP, Desreumaux P, Leteurtre E, et al. Mucin gene expression in intestinal epithelial cells in Crohn’s disease. Gut 2001 ; 49 : 544–551. [CrossRef] [PubMed]
  34. Zouiten-Mekki L, Serghini M, Fekih M, et al. Rôle de la cellule épithéliale dans l’homéostasie intestinale et les maladies inflammatoires chroniques de l’intestin. Med Sci (Paris) 2013 ; 29 : 1145–1150. [CrossRef] [EDP Sciences] [PubMed]
  35. Neunlist M, Van Landeghem L, Bourreille A, Savidge T. Neuro-glial crosstalk in inflammatory bowel disease. J Intern Med 2008 ; 263 : 577–583. [CrossRef] [PubMed]
  36. Savidge TC, Newman P, Pothoulakis C, et al. Enteric glia regulate intestinal barrier function and inflammation via release of S-nitrosoglutathione. Gastroenterology 2007 ; 132 : 1344–1358. [CrossRef] [PubMed]
  37. Neunlist M, Van Landeghem L, Mahe MM, et al. The digestive neuronal-glial-epithelial unit: a new actor in gut health and disease. Nat Rev Gastroenterol Hepatol 2013 ; 10 : 90–100. [CrossRef] [PubMed]
  38. Neunlist M, Toumi F, Oreschkova T, et al. Human ENS regulates the intestinal epithelial barrier permeability and a tight junction-associated protein ZO-1 via VIPergic pathways. Am J Physiol Gastrointest Liver Physiol 2003 ; 285 : G1028–G1036. [CrossRef] [PubMed]
  39. Neunlist M, Aubert P, Bonnaud S, et al. Enteric glia inhibit intestinal epithelial cell proliferation partly through a TGF-beta1-dependent pathway. Am J Physiol Gastrointest Liver Physiol 2007 ; 292 : G231–G241. [CrossRef] [PubMed]
  40. Villanacci V, Bassotti G, Nascimbeni R, et al. Enteric nervous system abnormalities in inflammatory bowel diseases. Neurogastroenterol Motil 2008 ; 20 : 1009–1016. [CrossRef] [PubMed]
  41. Barajon I, Serrao G, Arnaboldi F, et al. Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia. J Histochem Cytochem 2009 ; 57 : 1013–1023. [CrossRef] [PubMed]
  42. Ruhl A. Glial cells in the gut. Neurogastroenterol Motil 2005 ; 17 : 777–790. [CrossRef] [PubMed]
  43. Mosnier JF, Jarry A, Camdessanche JP, Antoine JC, Laboisse CL. In situ evidence of involvement of Schwann cells in ulcerative colitis: autocrine and paracrine signaling by A disintegrin and metalloprotease-17-mediated tumor necrosis factor alpha production. Hum Pathol 2009 ; 40 : 1159–1167. [CrossRef] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.